IOBT
▼next analysis
Prediction
BULLISH
Target
$2.24
Estimated
Model
trdz-T5k
Date
2025-09-15
09:37
Analyzed
IO Biotech, Inc. Price Analysis Powered by AI
IOBT: Breakout Above 2.00 Sets Up a Dip-and-Rip Toward 2.22–2.27 in the Next 24 Hours
Executive summary and directional bias
- Bias next 24 hours: Bullish continuation with a dip-and-rip profile favored. Expect initial pullback toward 2.00–2.04 followed by a push into 2.15–2.24, with stretch potential to 2.27.
- Core drivers: Fresh breakout above the 1.95–2.00 supply shelf on rising volume, price riding above key moving averages, improving momentum (RSI mid-60s), and supportive pivot cluster at 2.02–2.04.
Price structure and trend diagnostics
- Primary trend (daily): Up from the late-August pivot low (1.58 on Aug 28/29). Sequence of higher lows: 1.58 → 1.67 (Sep 2) → 1.75 (Sep 3) → 1.78–1.80 (Sep 4–10) → 1.91 (Sep 11), culminating in a new local closing high 2.08 (Sep 12). Structure supports continuation absent a decisive close back below 1.95–2.00.
- Supply-demand zones: 1.95–2.00 flipped from resistance to support on Sep 12. Next supply bands: 2.14–2.20 (recent pivot and upper Keltner band), 2.22–2.27 (July 31 pivot high zone), then 2.32–2.40 (late-July spike supply).
- Pattern context: Ascending triangle base between 1.75–1.95 resolved higher; Wyckoff read shows a Sign of Strength above resistance with an anticipated Last Point of Support retest around 1.98–2.03.
Candlestick and microstructure reads
- Sep 12 print: Strong bullish candle closing near high (2.08), signaling eager demand into the close. The two-session sequence (Sep 11–12) forms back-to-back bullish drives, often followed by either a shallow pullback or brief consolidation before continuation.
- Intraday expectation: After gap-less close near high, first-hour mean reversion toward the daily pivot area is likely before trend resumption.
Moving averages and trend filters
- 5-day SMA ≈ 1.87; 10-day SMA ≈ 1.81; 20-day SMA ≈ 1.82 (estimates from last closes). Price at 2.08 is above all three, with positive slope on 10/20-day, confirming short-term uptrend.
- 50-day SMA (approx) in the high 1.7s to low 1.8s given July–Aug regime; the stack 20 > 50 and price > all MAs is bullish.
- EMA posture: Faster EMAs (8–12) are above the 26 EMA; compression-expansion behavior favors momentum continuation.
Momentum oscillators
- RSI(14) ≈ 66: Bullish, not yet overbought (>70). Room for an extension to tag overbought on a push into 2.15–2.24.
- Stochastic (14): Near 100% after closing at the 14-session high. This flags short-term overbought but, during breakouts, often rides high while price advances. Expect shallow dips rather than deep pullbacks unless support fails.
- MACD: Positive and expanding histogram inferred from recent higher closes; signal-line cross likely occurred early September. Suggests momentum tailwind still active.
- ADX(14): Rising from low-to-mid teens toward 20–25 region (inferred), indicating a strengthening trend but not yet exhausted.
Volatility and bands
- Bollinger Bands (20,2): Mid-band ≈ 1.82 with upper band estimated around 2.17–2.19; Friday’s 2.08 close rides the upper half but leaves headroom to upper band, consistent with a continuation attempt.
- Keltner Channels (EMA20 ± 2xATR): With ATR(14) ≈ 0.16–0.18 and EMA20 ≈ 1.82, the upper KC resides near 2.14–2.18, aligning with first upside objective and potential stall zone before any pullback.
- ATR(14) ≈ 0.16–0.18: Expect daily range around 8–9% of price. A 2.08 close implies plausible intraday ranges of roughly 1.98–2.16 without outsized news.
Volume and money flow
- Volume trend: Sep 12 volume (~1.11M) above recent sessions and coincident with a resistance break — constructive. Post-Aug 11 capitulation spike has normalized, with accumulation reappearing in early September.
- OBV/Accumulation-Distribution: Rising since early September, confirming price advance with positive volume flow.
- Wyckoff lens: After the August washout (climactic volume on Aug 11), the stock transitioned to accumulation; the breakout above 1.95 suggests Markup Phase continuation. An LPS pullback into 1.98–2.03 is an attractive risk-defined buy area.
Market profile, VWAP, and anchored levels
- Traditional daily pivot map (based on Sep 12 H/L/C: 2.08/1.90/2.08):
- Pivot P ≈ 2.02; S1 ≈ 1.96; R1 ≈ 2.14; S2 ≈ 1.84; R2 ≈ 2.20; R3 ≈ 2.32.
- Implications: Buying near P (≈2.02) with targets at R1/R2 aligns with dip-buy strategy; S1 (≈1.96) is a natural stop reference.
- Anchored VWAP (qualitative): Anchoring to the Aug 11 event low and Aug 15 reversal likely places AVWAPs below current price, indicating current session holders are net in profit; this supports buy-the-dip behavior.
Fibonacci mapping
- Swing low to high: 1.58 (Aug 28–29) to 2.08 (Sep 12) = 0.50 range.
- Pullback retracements from 2.08: 38.2% ≈ 1.89, 50% ≈ 1.83, 61.8% ≈ 1.78. These align with SMA20 and prior breakout shelf, strengthening the 1.83–1.90 demand zone if a deeper pullback emerges.
- Extensions from 1.58: 1.272 ≈ 2.22, 1.618 ≈ 2.39. These harmonize with R2/R3 and prior supply, offering logical upside targets.
Ichimoku framework
- Tenkan (9-period mid) ≈ 1.82; Kijun (26-period mid) ≈ 1.88–1.90; price at 2.08 sits above both lines; bullish.
- Cloud: Span A ≈ 1.85; Span B ≈ 1.88–1.90; price is above a relatively flat cloud, which can act like a magnet on pullbacks but overall supports the uptrend while above 1.88–1.90.
Keltner vs. Bollinger confluence
- Upper KC (≈2.14) and BB upper (≈2.17–2.19) bracket the initial upside magnet zone; confluence of band ceilings often elicits first reaction. Expect scalers to trim into 2.14–2.19 on first test, with follow-through to 2.22 possible on persistent buying.
Elliott wave and fractal read (heuristic)
- From 1.58: Wave 1 to 1.75, Wave 2 to 1.67, Wave 3 to 1.95, Wave 4 to 1.77–1.80 range, Wave 5 to 2.08. If this labeling holds, a brief ABC pullback into 1.98–2.03 (A), 2.10 (B), 2.00–2.02 (C) could precede a higher degree advance toward 2.22–2.27.
Pattern and breakout validation checks
- Ascending triangle breakout: Confirmation requires holding above 1.95–2.00 on a closing basis, with volume on rallies exceeding that on pullbacks. Current condition satisfied; monitor volume-in-pullback character today.
Cross-method level clustering (confluence map)
- Support confluence: 1.98–2.04 (daily Pivot P, prior breakout line, shallow AVWAP area, intraday mean reversion). Secondary support 1.90–1.96 (S1, Kijun zone, 38.2% fib).
- Resistance confluence: 2.14–2.20 (R1–R2, upper Keltner, BB upper vicinity). Secondary 2.22–2.27 (fib 1.272, July 31 pivot zone). Extension: 2.32–2.40 (R3 and historical supply).
Scenario analysis (next 24 hours)
- Base case (55%): Early dip to 2.00–2.04, holds above 1.98, then momentum push to 2.14–2.20; late-day or after-hours probe into 2.22. Close 2.14–2.22.
- Bull case (25%): No meaningful dip; quick drive through 2.14, squeeze extends to 2.22–2.27; extreme print up to 2.30 on volume surge. Close ≥2.20.
- Bear case (20%): Fail to hold 1.98–2.00; slide to S1 1.96, with stop-runs testing 1.90–1.93. Close ≤1.96 would neutralize breakout and delay upside path.
Risk management and trade plan
- Entry plan: Buy-the-dip limit near 2.03 (around daily pivot), where risk is tight and reward to first resistance is favorable.
- Invalidation: A sustained break and close below 1.95 (S1 region) invalidates the immediate breakout-thesis for the next 24 hours.
- Upside targets: 2.14–2.20 (scale), 2.22–2.27 (primary TP zone). For this plan, set TP at 2.24 to capture the mid of the extension band.
- Stop concept (for context): Below 1.95 to avoid being trapped if support fails. Risk from 2.03 to 1.95 is ~0.08; reward to 2.24 is ~0.21, yielding an attractive R:R ≈ 2.6.
Additional indicators and checks
- Chaikin Money Flow: Likely positive given strong closes on up-volume; supports accumulation narrative.
- Vortex Indicator: VI+ expected above VI− in breakout phase; constructive while spreads widen.
- Heikin-Ashi: Recent bars would show larger bodies with minimal lower wicks, consistent with trend strength.
- Regression channel (20 sessions): Price near upper rail; brief mean reversion to midline (~1.95–2.00) fits buy-the-dip plan.
Catalyst and microcap caveats
- Biotech news risk remains elevated; after-hours or premarket headlines can overwhelm technicals. Use limits for entries, predefine exits, and respect stops.
Bottom line and forecast
- Momentum, volume, and multi-indicator confluence support a continuation higher after a modest intraday pullback. Optimal tactical entry sits near 2.03 with a 24-hour profit target near 2.24, expecting the 2.14–2.20 band to be tested and a brief extension toward 2.22–2.27 if buyers stay active.